0000000000803386

AUTHOR

Janusz Skalski

showing 2 related works from this author

Prognostic factors for non-asphyxia-related cardiac arrest patients undergoing extracorporeal rewarming - HELP Registry Study

2020

Objective: Extracorporeal rewarming is the treatment of choice for patients who had hypothermic cardiac arrest, allowing for best neurologic outcome. The authors’ goal was to identify factors associated with survival in nonasphyxia-related hypothermic cardiac arrest patients undergoing extracorporeal rewarming. Design: All 38 cardiac surgery departments in Poland were encouraged to report consecutive hypothermic cardiac arrest patients treated with extracorporeal life support. All variables collected were analyzed in order to compare survivor and nonsurvivor groups. The parameters available at the initiation of extracorporeal rewarming were considered as potential predictors of survival in …

extracorporeal circulationmedicine.medical_specialtycardiac arrestHypothermia030204 cardiovascular system & hematologyhyperlactatemiaExtracorporeallaw.invention03 medical and health sciences0302 clinical medicine030202 anesthesiologylawHumansMedicineRegistriesRewarmingSurvival rateRetrospective StudiesUnivariate analysisbusiness.industryExtracorporeal circulationRetrospective cohort studyout-of-hospitalPrognosisIntensive care unitCardiopulmonary ResuscitationHeart ArrestCardiac surgeryAnesthesiology and Pain MedicineLife supportAnesthesiaPolandCardiology and Cardiovascular Medicinebusiness
researchProduct

Endovascular mechanical thrombectomy of the inferior vena cava and iliac veins with the use of Aspirex®S device in a paediatric patient

2017

Phlegmasia cerulea dolens, which is the most severe clinical presentation of deep venous thrombosis and results from an almost complete occlusion of the major and collateral venous outflow routes from the extremity, is very rarely seen in children. Here we describe the treatment of an 11-year-old boy with Down syndrome who presented with thrombotic occlusion of the inferior vena cava and both iliac veins. We present a step-by-step technique of endovascular mechanical thrombectomy of these veins with the use of the Aspirex®S thrombectomy device. Endovascular treatment was followed by local intravenous thrombolysis. Because of recurrent thrombosis, which occurred 4 days later, endovascular th…

medicine.medical_specialtyendovascular mechanical thrombectomybusiness.industryPhlegmasia cerulea dolensmedicine.diseaseInferior vena cavaSurgeryMechanical thrombectomyAspirexIliac veinsmedicine.veincardiovascular systemMedicinecardiovascular diseasesbusinessPaediatric patientsPhlegmasia cerulea dolensPhlebological Review
researchProduct